Advertisement

Topics

FDA confirms issuance of voluntary action indicated inspection classification to Valeant

08:44 EDT 18 Aug 2017 | EPM Magazine

The FDA has confirmed its intent to issue a voluntary action indicated (VAI) inspection classification for Valeant Pharmaceuticals’ Tampa, Florida manufacturing facility as a part of an upcoming establishment inspection record.

Original Article: FDA confirms issuance of voluntary action indicated inspection classification to Valeant

NEXT ARTICLE

More From BioPortfolio on "FDA confirms issuance of voluntary action indicated inspection classification to Valeant"

Advertisement
Quick Search
Advertisement
Advertisement